Cargando…

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive malignancy with high incidence rate and poor prognosis. Enolase-1 (ENO1), a key glycolytic enzyme, has been implicated in the tumorigenesis of various cancers. However, its diagnostic value and clinical significance in HCC are unclear. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Weiwei, Li, Hongqiang, Yu, Yan, Chen, Jianan, Chen, Xiaolong, Ren, Fang, Ren, Zhigang, Cui, Guangying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245378/ https://www.ncbi.nlm.nih.gov/pubmed/30532594 http://dx.doi.org/10.2147/CMAR.S182183

Ejemplares similares

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
por: Feng, Honglei, et al.
Publicado: (2021)

Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma
por: Lin, Xian, et al.
Publicado: (2022)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
por: Bao, Jie, et al.
Publicado: (2018)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

CD44 is overexpressed and correlated with tumor progression in gallbladder cancer
por: He, Yuting, et al.
Publicado: (2018)

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage
por: Shi, Yue-Yu, et al.
Publicado: (2023)

Upregulation of miR‐374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer
por: Zhang, Jun, et al.
Publicado: (2018)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer
por: Xue, Chen, et al.
Publicado: (2018)

High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma
por: Wei, Yong-Guang, et al.
Publicado: (2022)

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
por: Ren, Zhigang, et al.
Publicado: (2019)

Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma
por: Wang, Kang, et al.
Publicado: (2015)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
por: Zhu, Kai, et al.
Publicado: (2013)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021)

Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zhang, Weiwei, et al.
Publicado: (2021)

CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
por: Peng, Qiliu, et al.
Publicado: (2022)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
por: Piñero, Federico, et al.
Publicado: (2020)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
por: Han, Yawei, et al.
Publicado: (2022)

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
por: Zhang, Lingyu, et al.
Publicado: (2021)

Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2020)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
por: Yoo, Wonbeak, et al.
Publicado: (2023)

Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma
por: Dai, Meiyu, et al.
Publicado: (2017)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
por: Hu, Xiaobo, et al.
Publicado: (2019)

Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression
por: Zhuang, Hao, et al.
Publicado: (2019)

Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer
por: Chen, Jianan, et al.
Publicado: (2019)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Expression signature of six‐snoRNA serves as novel non‐invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma
por: Zhao, Yanyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kbthkbm7d3nvn9ju6c1fbd1p2p